← Open Payments lookup

JOHN TIMKO: Open Payments

NPI 1700992948 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$47,383 in 180 payments from 13 companies in 2025. Trend: 2023 $28,726 · 2024 $51,737 · 2025 $47,383

Speaker / faculty: $43,957Food & beverage: $3,315Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.48$45,567
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)33$350
Neurocrine BioSciences, Inc.13$280
Alkermes, Inc.11$227
E.R. Squibb & Sons, L.L.C.28$195
Takeda Pharmaceuticals U.S.A., Inc.18$171
Teva Pharmaceuticals USA, Inc.4$160
Axsome Therapeutics, Inc.11$138
Lundbeck LLC6$134
Vanda Pharmaceuticals Inc.4$86

Products named: REXULTI, CAPLYTA, INGREZZA, LYBALVI, COBENFY, TRINTELLIX, Auvelity, FANAPT.

Industry payments across PA — which companies pay providers there.